21 results were returned
Bird & Bird has advised publicly traded Australian Elixinol Global Limited on the acquisition of leading German CBD company, CannaCare Health GmbH, Hamburg, by a Dutch subsidiary.
Our international Life Sciences & Healthcare Group is extremely proud to have been recognised among individuals and companies behind the most innovative and challenging Life Sciences work of the past year, as well as ...
International law firm Bird & Bird advised global safety equipment manufacturer MSA Safety Incorporated (NYSE: MSA) on the acquisition of U.K.-based Bristol Uniforms (“Bristol”) in an all-cash transaction valued at ...
Bird & Bird LLP has advised the US company InGeneron on the sale of 100% of the shares in the Munich-based private umbilical cord blood banking company Eticur GmbH to Polski Bank Komórek Macierzystych.
The Swedish listed company AddLife AB is a market leading player within Life Science offering quality products and advice to both the private and the public sectors, primarily in the Nordics and the rest of Europe.
Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...
International law firm Bird & Bird today expands its Corporate practice group with the appointment of James Baillieu as a partner in London.
Our Equity Capital Markets Team has completed a number of deals this Quarter, across a wide variety of sectors.
The Court of Justice provided guidance for the antitrust assessment of agreements between competitors in the pharmaceutical sector. The Court's judgment is relevant because it addresses fundamental issues that have been ...
We are pleased to issue the latest edition of Bird & Bird's PLC Update, a periodical publication containing recent developments in the Equity Capital Markets arena.
We hope that you enjoy reading our PLC Update. Please ...